Medtronic Stock Forecast, Price & News

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 4 hold ratings and 18 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic or view top-rated stocks.

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medtronic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Medtronic saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 11,050,000 shares, an increase of 19.3% from the June 30th total of 9,260,000 shares. Based on an average daily volume of 4,250,000 shares, the days-to-cover ratio is presently 2.6 days. Approximately 0.8% of the company's shares are sold short.
View Medtronic's Short Interest.

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, August 24th 2021.
View our earnings forecast for Medtronic.

Medtronic will be holding an earnings conference call on Tuesday, August 24th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Medtronic plc (NYSE:MDT) announced its earnings results on Wednesday, May, 26th. The medical technology company reported $1.50 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.08. The medical technology company had revenue of $8.19 billion for the quarter, compared to analysts' expectations of $8.13 billion. Medtronic had a net margin of 11.98% and a trailing twelve-month return on equity of 11.82%. The business's quarterly revenue was up 36.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.58 earnings per share.
View Medtronic's earnings history.

Medtronic's stock was trading at $92.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MDT shares have increased by 42.2% and is now trading at $131.46.
View which stocks have been most impacted by COVID-19.

Medtronic declared a quarterly dividend on Thursday, May 27th. Stockholders of record on Friday, June 25th will be paid a dividend of $0.63 per share on Friday, July 16th. This represents a $2.52 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend is Thursday, June 24th. This is an increase from Medtronic's previous quarterly dividend of $0.58.
View Medtronic's dividend history.

Medtronic pays an annual dividend of $2.52 per share and currently has a dividend yield of 1.92%.
View Medtronic's dividend history.

Medtronic updated its FY 2022 earnings guidance on Tuesday, June, 22nd. The company provided EPS guidance of $5.600-5.750 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.720. The company issued revenue guidance of -.

22 brokers have issued 12-month price targets for Medtronic's stock. Their forecasts range from $115.00 to $153.00. On average, they anticipate Medtronic's share price to reach $135.14 in the next year. This suggests a possible upside of 2.8% from the stock's current price.
View analysts' price targets for Medtronic or view top-rated stocks among Wall Street analysts.

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Baxter International (BAX), Hologic (HOLX), STERIS (STE), Insulet (PODD), Teleflex (TFX) and Masimo (MASI).
View all of MDT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Alliancebernstein L.P. (0.70%), Diamond Hill Capital Management Inc. (0.34%), New York State Common Retirement Fund (0.24%), Flossbach Von Storch AG (0.18%), Fisher Asset Management LLC (0.17%) and DAVENPORT & Co LLC (0.09%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert John White.
View institutional ownership trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Alliancebernstein L.P., PGGM Investments, Clark Capital Management Group Inc., Flossbach Von Storch AG, TCW Group Inc., Beach Investment Counsel Inc. PA, and Davy Global Fund Management Ltd. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Omar Ishrak, and Robert John White.
View insider buying and selling activity for Medtronic or view top insider-selling stocks.

MDT stock was purchased by a variety of institutional investors in the last quarter, including Capital Wealth Planning LLC, Diamond Hill Capital Management Inc., Zurcher Kantonalbank Zurich Cantonalbank , Fisher Asset Management LLC, Victory Capital Management Inc., DAVENPORT & Co LLC, Calamos Advisors LLC, and Argyle Capital Management Inc.. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic or or view top insider-buying stocks.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDT stock can currently be purchased for approximately $131.46.

Medtronic has a market capitalization of $176.67 billion and generates $30.12 billion in revenue each year.

Medtronic employs 90,000 workers across the globe.

Medtronic was founded in 1949.

The official website for Medtronic is www.medtronic.com.

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at (531) 438-1700 or via email at [email protected]